Edmond de Rothschild (Europe)’s Regeneron Pharmaceuticals REGN Stock Holding History

Edmond de Rothschild (Europe)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$28K	Buy	+70	New	+$28.1K	0.01%	200

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Edmond de Rothschild (Europe)'s REGN Position: Q3 2016 in Review

Edmond de Rothschild (Europe) opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2016: 70 shares worth $28K. The stake represents 0.01% of the portfolio and ranks #200 among its holdings.

554 funds tracked by Wall St. Rank hold REGN as of Q3 2016.

Edmond de Rothschild (Europe) held 70 shares of Regeneron Pharmaceuticals worth $28K as of Q3 2016.
Regeneron Pharmaceuticals was a new Edmond de Rothschild (Europe) position in Q3 2016.
Regeneron Pharmaceuticals made up 0.01% of Edmond de Rothschild (Europe)'s portfolio in Q3 2016, its #200 holding.
554 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2016.

Based on Edmond de Rothschild (Europe)'s 13F filing for Q3 2016, filed 14 Nov 2016.